blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2652126

EP2652126 - TREATMENT OF IMMUNE-RELATED DISEASES AND DISORDERS USING AMNION DERIVED ADHERENT CELLS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.05.2017
Database last updated on 31.08.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Anthrogenesis Corporation
7 Powder Horn Drive
Warren, NJ 07059 / US
[2013/43]
Inventor(s)01 / ABBOT, Stewart
15 Casale Drive
Warren, NJ 07059 / US
02 / EDINGER, James, W.
273 Leonardville Road
Belford, NJ 07718 / US
03 / FRANCKI, Aleksandar
80 La Costa Drive
Annandale, NJ 08801 / US
04 / JANKOVIC, Vladimir
10 River Road, Apt.15B
New York, NY 10044 / US
05 / LIANG, Bitao
65 Bethany Circle
Closter, NJ 07624 / US
 [2016/28]
Former [2014/05]01 / ABBOT, Stewart
15 Casale Drive
Warren, NJ 07059 / US
02 / EDINGER, James, W.
273 Leonardville Road
Belford, NJ 07718 / US
03 / FRANCKI, Aleksandar
80 La Costa Drive
Annandale, NJ 08801 / US
04 / JANKOVIC, Vladimir
10 River Road Apt., 15B
New York, NY 10044 / US
05 / LIANG, Bitao
65 Bethany Circle
Closter, NJ 07624 / US
Former [2014/03]01 / ABBOT, Stewart
15 Casale Drive
Warren, NJ 07059 / US
02 / EDINGER, James, W.
273 Leonardville Road
Belford, NJ 07718 / US
03 / FRANCKI, Aleksandar
80 La Costa Drive
Annandale, NJ 08801 / US
04 / JANKOVIC, Vladimir
30 River Road Apt., 4D
New York, NY 10044 / US
05 / LIANG, Bitao
65 Bethany Circle
Closter, NJ 07624 / US
Former [2013/43]01 / ABBOT, Stewart
15 Casale Drive
Warren NJ 07059 / US
02 / EDINGER, James, W.
273 Leonardville Road
Belford NJ 07718 / US
03 / FRANCKI, Aleksandar
80 La Costa Drive
Annandale NJ 08801 / US
04 / JANKOVIC, Vladimir
30 River Road Apt., 4D
New York NY 10044 / US
05 / LIANG, Bitao
65 Bethany Circle
Closter NJ 07624 / US
Representative(s)Bezzubova, Olga, et al
Jones Day
Prinzregentenstraße 11
80538 München / DE
[2013/43]
Application number, filing date11849864.115.12.2011
[2016/28]
WO2011US65158
Priority number, dateUS201061424593P17.12.2010         Original published format: US 201061424593 P
[2013/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012083021
Date:21.06.2012
Language:EN
[2012/25]
Type: A1 Application with search report 
No.:EP2652126
Date:23.10.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 21.06.2012 takes the place of the publication of the European patent application.
[2013/43]
Type: B1 Patent specification 
No.:EP2652126
Date:13.07.2016
Language:EN
[2016/28]
Search report(s)International search report - published on:US21.06.2012
(Supplementary) European search report - dispatched on:EP10.04.2014
ClassificationIPC:C12N5/071, A61K35/50, C12N5/073, C12N5/0775, A61K35/12
[2014/20]
CPC:
C12N5/0605 (EP,KR,US); A61K35/50 (EP,KR,US); A61K35/17 (KR);
A61P1/00 (EP); A61P1/02 (EP); A61P1/04 (EP);
A61P1/12 (EP); A61P1/14 (EP); A61P1/16 (EP);
A61P11/00 (EP); A61P11/02 (EP); A61P11/06 (EP,KR);
A61P13/02 (EP); A61P13/10 (EP); A61P13/12 (EP);
A61P15/02 (EP); A61P15/08 (EP); A61P17/00 (EP);
A61P17/02 (EP); A61P17/06 (EP); A61P17/14 (EP);
A61P19/00 (EP); A61P19/02 (EP); A61P19/04 (EP);
A61P21/00 (EP); A61P21/02 (EP); A61P21/04 (EP);
A61P25/00 (EP); A61P25/02 (EP); A61P25/08 (EP);
A61P25/14 (EP); A61P25/18 (EP); A61P25/26 (EP);
A61P27/02 (EP); A61P27/16 (EP); A61P29/00 (EP);
A61P3/02 (EP); A61P3/10 (EP); A61P31/12 (EP);
A61P35/00 (EP); A61P37/00 (EP); A61P37/02 (EP,KR);
A61P37/06 (EP); A61P37/08 (EP,KR); A61P43/00 (EP);
A61P5/16 (EP); A61P5/40 (EP); A61P7/00 (EP);
A61P7/04 (EP); A61P7/06 (EP); A61P9/00 (EP);
A61P9/04 (EP); A61P9/08 (EP); A61P9/10 (EP);
C12N5/0668 (EP,KR,US); A61K2035/122 (EP,KR,US); C12N2509/00 (EP,US) (-)
Former IPC [2013/43]C12N5/071
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/43]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:BEHANDLUNG IMMUNBEDINGTER ERKRANKUNGEN UND STÖRUNGEN UNTER VERWENDUNG VON AUS AMNION GEWONNENEN ADHÄRENTEN ZELLEN[2013/43]
English:TREATMENT OF IMMUNE-RELATED DISEASES AND DISORDERS USING AMNION DERIVED ADHERENT CELLS[2013/43]
French:TRAITEMENT DE MALADIES ET DE TROUBLES LIÉS À LA RÉPONSE IMMUNE AU MOYEN DE CELLULES ADHÉRENTES DÉRIVÉES DE L'AMNIOS[2013/43]
Entry into regional phase25.06.2013National basic fee paid 
25.06.2013Search fee paid 
25.06.2013Designation fee(s) paid 
25.06.2013Examination fee paid 
Examination procedure25.06.2013Examination requested  [2013/43]
24.10.2014Amendment by applicant (claims and/or description)
02.04.2015Despatch of a communication from the examining division (Time limit: M04)
28.07.2015Reply to a communication from the examining division
12.02.2016Communication of intention to grant the patent
12.05.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
12.05.2016Fee for grant paid
12.05.2016Fee for publishing/printing paid
07.06.2016Information about intention to grant a patent
07.06.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.04.2015
Opposition(s)18.04.2017No opposition filed within time limit [2017/25]
Fees paidRenewal fee
27.12.2013Renewal fee patent year 03
29.12.2014Renewal fee patent year 04
28.12.2015Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.12.2011
AL13.07.2016
AT13.07.2016
BE13.07.2016
CY13.07.2016
CZ13.07.2016
DK13.07.2016
EE13.07.2016
FI13.07.2016
HR13.07.2016
LT13.07.2016
LV13.07.2016
MC13.07.2016
MK13.07.2016
NL13.07.2016
PL13.07.2016
RO13.07.2016
RS13.07.2016
SE13.07.2016
SI13.07.2016
SK13.07.2016
SM13.07.2016
TR13.07.2016
BG13.10.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
LU15.12.2016
MT15.12.2016
[2018/46]
Former [2018/45]HU15.12.2011
AT13.07.2016
BE13.07.2016
CY13.07.2016
CZ13.07.2016
DK13.07.2016
EE13.07.2016
FI13.07.2016
HR13.07.2016
LT13.07.2016
LV13.07.2016
MC13.07.2016
MK13.07.2016
NL13.07.2016
PL13.07.2016
RO13.07.2016
RS13.07.2016
SE13.07.2016
SI13.07.2016
SK13.07.2016
SM13.07.2016
TR13.07.2016
BG13.10.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
LU15.12.2016
MT15.12.2016
Former [2018/43]HU15.12.2011
AT13.07.2016
BE13.07.2016
CY13.07.2016
CZ13.07.2016
DK13.07.2016
EE13.07.2016
FI13.07.2016
HR13.07.2016
LT13.07.2016
LV13.07.2016
MC13.07.2016
MK13.07.2016
NL13.07.2016
PL13.07.2016
RO13.07.2016
RS13.07.2016
SE13.07.2016
SI13.07.2016
SK13.07.2016
SM13.07.2016
BG13.10.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
LU15.12.2016
MT15.12.2016
Former [2018/28]HU15.12.2011
AT13.07.2016
BE13.07.2016
CY13.07.2016
CZ13.07.2016
DK13.07.2016
EE13.07.2016
FI13.07.2016
HR13.07.2016
LT13.07.2016
LV13.07.2016
MC13.07.2016
MK13.07.2016
NL13.07.2016
PL13.07.2016
RO13.07.2016
RS13.07.2016
SE13.07.2016
SI13.07.2016
SK13.07.2016
SM13.07.2016
BG13.10.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
LU15.12.2016
Former [2017/49]AT13.07.2016
BE13.07.2016
CZ13.07.2016
DK13.07.2016
EE13.07.2016
FI13.07.2016
HR13.07.2016
LT13.07.2016
LV13.07.2016
MC13.07.2016
NL13.07.2016
PL13.07.2016
RO13.07.2016
RS13.07.2016
SE13.07.2016
SI13.07.2016
SK13.07.2016
SM13.07.2016
BG13.10.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
LU15.12.2016
Former [2017/45]AT13.07.2016
BE13.07.2016
CZ13.07.2016
DK13.07.2016
EE13.07.2016
FI13.07.2016
HR13.07.2016
LT13.07.2016
LV13.07.2016
MC13.07.2016
NL13.07.2016
PL13.07.2016
RO13.07.2016
RS13.07.2016
SE13.07.2016
SI13.07.2016
SK13.07.2016
SM13.07.2016
BG13.10.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
Former [2017/37]AT13.07.2016
BE13.07.2016
CZ13.07.2016
DK13.07.2016
EE13.07.2016
FI13.07.2016
HR13.07.2016
LT13.07.2016
LV13.07.2016
NL13.07.2016
PL13.07.2016
RO13.07.2016
RS13.07.2016
SE13.07.2016
SI13.07.2016
SK13.07.2016
SM13.07.2016
BG13.10.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
Former [2017/31]AT13.07.2016
BE13.07.2016
CZ13.07.2016
DK13.07.2016
EE13.07.2016
FI13.07.2016
HR13.07.2016
LT13.07.2016
LV13.07.2016
NL13.07.2016
PL13.07.2016
RO13.07.2016
RS13.07.2016
SE13.07.2016
SK13.07.2016
SM13.07.2016
BG13.10.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
Former [2017/13]AT13.07.2016
BE13.07.2016
FI13.07.2016
HR13.07.2016
LT13.07.2016
LV13.07.2016
NL13.07.2016
PL13.07.2016
RS13.07.2016
SE13.07.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
Former [2017/11]AT13.07.2016
BE13.07.2016
FI13.07.2016
HR13.07.2016
LT13.07.2016
NL13.07.2016
PL13.07.2016
RS13.07.2016
SE13.07.2016
NO13.10.2016
GR14.10.2016
IS13.11.2016
PT14.11.2016
Former [2017/10]BE13.07.2016
FI13.07.2016
HR13.07.2016
LT13.07.2016
NL13.07.2016
PL13.07.2016
RS13.07.2016
SE13.07.2016
NO13.10.2016
IS13.11.2016
Former [2017/09]FI13.07.2016
LT13.07.2016
NL13.07.2016
NO13.10.2016
Former [2017/07]LT13.07.2016
Documents cited:Search[Y]WO2008100498  (ANTHROGENESIS CORPARATION [US], et al);
 [X]WO2010059828  (ANTHROGENESIS CORP [US], et al);
 [XP]WO2011064669  (PLURISTEM LTD [IL], et al);
International search[Y]US2009124573  (MAZMANIAN SARKIS [US], et al);
 [X]US2010124569  (ABBOT STEWART [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.